APAthanasios Pavlou

Athanasios Pavlou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Athanasios Pavlou has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Human Judgment and the Limits of Artificial Intelligence for Automated Rank Order Lists in Diagnostic Radiology Residency Selection

    by Cody H. Savage, Rydhwana Hossain, James (Mac) Tonascia, Athanasios Pavlou, Charles S. Resnik, Florence X. Doo, Elana B. Smith


  • Open Access

    Orbital Magnetic Resonance Imaging of Ocular Giant Cell Arteritis: A Systematic Review and Individual Participant Data Meta-Analysis

    by Konstanze V. Guggenberger, Athanasios Pavlou, Quy Cao, Ishaan J. Bhatt, Qi N. Cui, Thorsten A. Bley, Hugh D. Curtin, Julien Savatovsky, Jae W. Song

    Objectives: We conducted a systematic review and individual participant data meta-analysis of publications reporting the ophthalmologic presentation, clinical exam, and orbital MRI findings in ocular giant cell arteritis. Methods: PubMed and Cochrane databases were searched up to January 16, 2022. Publications reporting patient-level data on patients with ophthalmologic symptoms, imaged with orbital MRI and diagnosed with biopsy-proven giant cell arteritis were included. Demographics, clinical symptoms, exam, lab, imaging, and outcomes data were extracted. Methodological quality and completeness of reporting of case reports were assessed. Results: Thirty-two studies were included comprising 51 patients (females=24; median age, 76 years). Vision loss (78%) and headache (45%) were commonly reported visual and cranial symptoms. Ophthalmologic presentation was unilateral (41%) or bilateral (59%). Fundus examination most commonly showed disc edema (64%) and pallor (49%). Average visual acuity was very poor (2.28 logMAR ± 2.18). Diagnoses included anterior (61%) and posterior (16%) ischemic optic neuropathy, central retinal artery occlusion (8%) and orbital infarction syndrome (2%). On MRI, enhancement of the optic nerve sheath (53%), intraconal fat (25%), and optic nerve/chiasm (14%) was most prevalent. Among patients with monocular visual symptoms, 38% showed pathologic enhancement in the asymptomatic eye. Six of seven cases reported imaging resolution after treatment on follow-up MRIs. Conclusions: Vision loss, pallid disc edema, and optic nerve sheath enhancement are the most common clinical, fundoscopic and imaging findings reported in patients diagnosed with ocular giant cell arteritis, respectively. MRI may detect subclinical inflammation in the asymptomatic eye and may be an adjunct diagnostic tool. Key Points: Among 32 publications comprising 51 patients with biopsy-proven giant cell arteritis, vision loss, pallid disc edema, and optic nerve sheath enhancement were the most commonly reported clinical, fundoscopic and orbital MRI findings, respectively. Orbital MRI detected subclinical inflammation in the asymptomatic orbit in 38% of giant cell arteritis patients presenting with monocular visual symptoms. MRI may have a diagnostic role in patients with suspected giant cell arteritis and presenting with acute visual symptoms.

  • Open Access

    Diagnostic Accuracy Studies in Radiology: How to Recognize and Address Potential Sources of Bias

    by Athanasios Pavlou, Robert M. Kurtz, Jae W. Song

    Accuracy is an important parameter of a diagnostic test. Studies that attempt to determine a test’s accuracy can suffer from various forms of bias. As radiology is a diagnostic specialty, many radiologists may design a diagnostic accuracy study or review one to understand how it may apply to their practice. Radiologists also frequently serve as consultants to other physicians regarding the selection of the most appropriate diagnostic exams. In these roles, understanding how to critically appraise the literature is important for all radiologists. The purpose of this review is to provide a framework for evaluating potential sources of study design biases that are found in diagnostic accuracy studies and to explain their impact on sensitivity and specificity estimates. To help the reader understand these biases, we also present examples from the radiology literature.


  • Vessel wall MR imaging of central nervous system vasculitis: a systematic review

    by Nathan Arnett, Athanasios Pavlou, Morgan P. Burke, Brett L. Cucchiara, Rennie L. Rhee, Jae W. Song

    Purpose Beyond vessel wall enhancement, little is understood about vessel wall MR imaging (VW-MRI) features of vasculitis affecting the central nervous system (CNS). We reviewed vessel wall MR imaging patterns of inflammatory versus infectious vasculitis and also compared imaging patterns for intracranial versus extracranial arteries of the head and neck. Methods Studies reporting vasculitis of the CNS/head and neck and included MR imaging descriptions of vessel wall features were identified by searching PubMed, Scopus, Cochrane, Web of Science, and EMBASE up to June 10, 2020. From 6065 publications, 115 met the inclusion criteria. Data on study characteristics, vasculitis type, MR details, and VW-MRI descriptions were extracted. Results Studies used VW-MRI for inflammatory (64%), infectious (17%), or both inflammatory and infectious vasculitides (19%). Vasculitis affecting intracranial versus extracranial arteries were reported in 58% and 39% of studies, respectively. Commonly reported VW-MRI features were vessel wall enhancement (89%), thickening (72%), edema (10%), and perivascular enhancement (16%). Inflammatory vasculitides affecting the intracranial arteries were less frequently reported to have vessel wall thickening (p = 0.006) and perivascular enhancement (p = 0.001) than extracranial arteries. Varicella zoster/herpes simplex vasculitis (VZV/HSV, 45%) and primary angiitis of the CNS (PACNS, 22%) were the most commonly reported CNS infectious and inflammatory vasculitides, respectively. Patients with VZV/HSV vasculitis more frequently showed decreased or resolution of vessel wall enhancement after therapy compared to PACNS (89% versus 59%). Conclusions To establish imaging biomarkers of vessel wall inflammation in the CNS, VW-MRI features of vasculitis accounting for disease mechanism and anatomy should be better understood.


  • Top Cited Papers

    Vessel Wall Magnetic Resonance Imaging Biomarkers of Symptomatic Intracranial Atherosclerosis

    by Jae W. Song, Athanasios Pavlou, Jiayu Xiao, Scott E. Kasner, Zhaoyang Fan, Steven R. Messé

    Background and Purpose: Intracranial atherosclerotic disease is a common cause of stroke worldwide. Intracranial vessel wall magnetic resonance imaging may be able to identify imaging biomarkers of symptomatic plaque. We performed a meta-analysis to evaluate the strength of association of imaging features of symptomatic plaque leading to downstream ischemic events. Effects on the strength of association were also assessed accounting for possible sources of bias and variability related to study design and magnetic resonance parameters. Methods: PubMed, Scopus, Web of Science, EMBASE, and Cochrane databases were searched up to October 2019. Two independent reviewers extracted data on study design, vessel wall magnetic resonance imaging techniques, and imaging end points. Per-lesion odds ratios (OR) were calculated and pooled using a bivariate random-effects model. Subgroup analyses, sensitivity analysis, and evaluation of publication bias were also performed. Results: Twenty-one articles met inclusion criteria (1750 lesions; 1542 subjects). Plaque enhancement (OR, 7.42 [95% CI, 3.35–16.43]), positive remodeling (OR, 5.60 [95% CI, 2.23–14.03]), T1 hyperintensity (OR, 2.05 [95% CI, 1.27–3.32]), and surface irregularity (OR, 4.50 [95% CI, 1.39–8.57]) were significantly associated with downstream ischemic events. T2 signal intensity was not significant ( P =0.59). Plaque enhancement was significantly associated with downstream ischemic events in all subgroup analyses and showed stronger associations when measured in retrospectively designed studies ( P =0.02), by a radiologist as a rater ( P P =0.02). Conclusions: Plaque enhancement, positive remodeling, T1 hyperintensity, and surface irregularity emerged as strong imaging biomarkers of symptomatic plaque in patients with ischemic events. Plaque enhancement remained significant accounting for sources of bias and variability in both study design and instrument. Future studies evaluating plaque enhancement as a predictive marker for stroke recurrence with larger sample sizes would be valuable.


  • Imaging endpoints of intracranial atherosclerosis using vessel wall MR imaging: a systematic review

    by Jae W. Song, Athanasios Pavlou, Morgan P. Burke, Haochang Shou, Kofi-Buaku Atsina, Jiayu Xiao, Laurie A. Loevner, David Mankoff, Zhaoyang Fan, Scott E. Kasner

    Purpose The vessel wall MR imaging (VWI) literature was systematically reviewed to assess the criteria and measurement methods of VWI-related imaging endpoints for symptomatic intracranial plaque in patients with ischemic events. Methods PubMed, Scopus, Web of Science, EMBASE, and Cochrane databases were searched up to October 2019. Two independent reviewers extracted data from 47 studies. A modified Guideline for Reporting Reliability and Agreement Studies was used to assess completeness of reporting. Results The specific VWI-pulse sequence used to identify plaque was reported in 51% of studies. A VWI-based criterion to define plaque was reported in 38% of studies. A definition for culprit plaque was reported in 40% of studies. Frequently scored qualitative imaging endpoints were plaque quadrant (21%) and enhancement (21%). Frequently measured quantitative imaging endpoints were stenosis (19%), lumen area (15%), and remodeling index (14%). Reproducibility for all endpoints ranged from good to excellent (range: ICCT1 hyperintensity = 0.451 to ICCstenosis = 0.983). However, rater specialty and years of experience varied among studies. Conclusions Investigators are using different criteria to identify and measure VWI-imaging endpoints for culprit intracranial plaque. Early awareness of these differences to address methods of acquisition and measurement will help focus research resources and efforts in technique optimization and measurement reproducibility. Consensual definitions to detect plaque will be important to develop automatic lesion detection tools particularly in the era of radiomics.